Fri.Jun 03, 2022

article thumbnail

Bristol Myers bets $4B on Turning Point and its targeted cancer drugs

Bio Pharma Dive

Dive Brief: Bristol Myers Squibb is buying biotech Turning Point Therapeutics, announcing Friday a $4.1 billion deal that will give the pharmaceutical company an experimental drug that targets mutations found in lung cancer and other solid tumors. The deal values Turning Point at $76 a sh.

Drugs 294
article thumbnail

How Xook is Modernizing the Cafeteria Landscape

XTalks

Xook , a developer of robotic fresh food kiosks, recently raised $1.3 million in a pre-seed funding round from a group that includes SRI Capital, Pitchright Ventures, a handful of angel investors and tech accelerators. The food tech startup is now eyeing the US for the rollout of its “food courts in a box.”. Xook created automatic cafeterias, similar to the size of vending machines or kiosks, that make snacks and simple foods based on pre-fed ingredients.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA extends review of Amylyx ALS drug, delaying approval decision

Bio Pharma Dive

The agency said it wanted more time to assess additional clinical trial data submitted by Amylyx, and set a new decision date of Sept. 29 for the closely watched treatment.

article thumbnail

3D Heart Modeling Solution By inHEART Gets FDA Clearance

XTalks

A new 3D heart modeling solution by inHEART received FDA 510(k) clearance. The modeling solution allows for 3D visualization and analysis of the heart for pre-procedural planning and intraprocedural use. Photo courtesy of inHEART. Heart rhythm problems and an irregular heartbeat (arrhythmia) can be corrected with a cardiac ablation procedure, often done when medications or other treatments are not working.

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Synthesis of tetraphenylammonium, a phantom ion whose existence had not been confirmed

Scienmag

[Background] Credit: Kanazawa University [Background] Since the benzene ring is a representative constituent of organic compounds, a structure consisting only of a common element plus the benzene ring is considered to be one of the most fundamental chemical skeletons. Due to their importance, chemical synthesis of such molecules has been studied since the early days […].

91
article thumbnail

21 Americans Infected With Monkeypox, C.D.C. Reports

NY Times

As the number of cases outside Africa approaches 800, governments are scrambling for a limited pool of vaccines and treatments with unclear effectiveness.

More Trending

article thumbnail

New patent for Clarus drug JATENZO

Drug Patent Watch

Annual Drug Patent Expirations for JATENZO Jatenzo is a drug marketed by Clarus and is included in one NDA. It is available from one supplier. There are seven patents protecting…. The post New patent for Clarus drug JATENZO appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

How we choose to end deforestation will impact future emissions

Scienmag

The Glasgow Leaders’ Declaration on Forests and Land Use signed at COP26 represents a commitment by leaders representing over 85% of the world’s forests to halt and reverse deforestation and land degradation by 2030. But could the declaration’s ambitions be too ambiguous? An international team of researchers looked into this question. Credit: Adam Islaam | […].

article thumbnail

¿Los probióticos vaginales funcionan?

NY Times

Píldoras y supositorios vaginales que prometen equilibrar el microbioma vaginal llenan los estantes de las farmacias y la tiendas en línea. ¿Son seguros y efectivos?

Drugs 53
article thumbnail

Grain boundaries go with the flow

Scienmag

HOUSTON – (June 6, 2022) – Rice University engineers who mimic atom-scale processes to make them big enough to see have modeled how shear influences grain boundaries in polycrystalline materials. Credit: Biswal Research Group/Rice University HOUSTON – (June 6, 2022) – Rice University engineers who mimic atom-scale processes to make them big enough to see have modeled how shear influences grain boundaries in polycrystalline materials.

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Digital health is overrated but there is a future

World of DTC Marketing

The continued emphasis on digital health is overrated but digital health will become an integral part of total patient care. To become a vital part of patient care, digital health providers need to provide the medical community with studies that show their value to patient outcomes. The rapid advancement in the digital healthcare field brings many advantages and a few problems that shouldn’t be ignored.

Doctors 291
article thumbnail

A novel path for sustainable photon upconversion with non-precious metals

Scienmag

Sustainable chemical applications need to be able to employ renewable energy sources, renewable raw materials, and earth-abundant elements. However, to date many techniques have only been possible with the use of expensive precious metals or rare earth metals, the extraction of which can have serious environmental impacts. A team of researchers including Professor Katja Heinze […].

article thumbnail

Which drugs have supplementary protection certificates in the most countries?

Drug Patent Watch

This chart shows the drugs with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long…. The post Which drugs have supplementary protection certificates in the most countries? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Researchers establish a profile of the COVID-19 deceased based on the analysis of 140 cases of complete autopsies

Scienmag

Men aged between 60 and 77 with Diffuse Alveolar Damage (DAD) –acute lung injury– in proliferative phase. This is the most frequent profile of the deceased from COVID-19, as identified by researchers of the Department of Legal and Forensic Medicine of the University of Malaga after analyzing 140 cases of complete autopsies. Credit: University of […].

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Targeted drug achieves 43% response rate in KRAS-mutated lung cancer

Scienmag

BOSTON – Nearly 43% of patients with non-small cell lung cancer (NSCLC) whose lung cancers harbored a specific KRAS mutation responded to the experimental drug adagrasib, and the targeted agent also showed activity against lesions in the brain that metastasized from the lung tumors, according to results of a study led by Dana-Farber Cancer Institute […].

Drugs 86
article thumbnail

RAPID shuttle service recognized with Excellence Award

Scienmag

A team from The University of Texas at Arlington’s Parking and Transportation Services (PATS) and Department of Civil Engineering received an award for its work on RAPID (Rideshare, Automation, and Payment Integration Demonstration), the on-demand, self-driving shuttle service. Credit: UT Arlington A team from The University of Texas at Arlington’s Parking and Transportation Services (PATS) […].

article thumbnail

New drug combination lengthens survival for some with lung cancer

Scienmag

A combination of the drugs ramucirumab and pembrolizumab reduced risk of death by 31% compared with the standard of care in patients with advanced non-small cell lung cancer that had progressed on prior immunotherapy. Patients with advanced non-small cell lung cancer whose cancer had progressed on previous immunotherapy lived significantly longer when subsequently treated […].

Drugs 83
article thumbnail

Polarstern II: German Bundestag green-lights the construction of new icebreaker

Scienmag

The Research Vessel Polarstern has been underway in the Arctic and Antarctic for 40 years now, giving experts from around the globe the opportunity to safely and effectively conduct research in two of the most extreme regions on our planet. It was instrumental in the Federal Republic of Germany assuming a leading role in polar […].

article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Novel immunotherapy mechanism suppresses breast cancer development

Scienmag

Credit: Emanuela Marchese, PhD Journal Journal of Experimental Medicine DOI 10.1084/jem.20201963 Method of Research Experimental study Subject of Research Animals Article Title CD4+ T helper 2 cells suppress breast cancer by inducing terminal differentiation Article Publication Date 3-Jun-2022 COI Statement Disclosures: M. Boieri is an employee of Zelluna Immunotherapy.

article thumbnail

Computer vision tool improves the ability to distinguish rheumatoid arthritis from osteoarthritis in damaged joint tissue

Scienmag

A new study led by Hospital for Special Surgery (HSS) investigators in New York City has found that their computer vision tool effectively distinguishes rheumatoid arthritis (RA) from osteoarthritis (OA) in joint tissue taken from patients who underwent total knee replacement (TKR). The results suggest the machine learning model will help improve research processes in […].

article thumbnail

DNA moves steadily during interphase, providing cells robust housekeeping system

Scienmag

Researchers in Japan have discovered that the local DNA motion inside of human cells remains steady throughout interphase, where the cell grows and replicates its DNA for cell division. The study suggests that this steady-state DNA motion allows cells to conduct housekeeping tasks under similar environments during interphase. Credit: Shiori Iida & Kazuhiro Maeshima, National […].

DNA 80
article thumbnail

Mutations differ across younger and older breast cancer patients

Scienmag

Women younger than 40 years of age with advanced breast cancer often suffer from more aggressive disease and worse prognoses than their older counterparts. Knowing which types of genetic mutations these patients tend to have could inform treatment strategies and improve outcomes. In a new study, Yale Cancer Center researchers investigated the genomic alterations of […].

Genome 86
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

University of Jyväskylä project wants to replace passwords with a more secure solution

Scienmag

Our everyday lives are protected by passwords on many levels. Passwords protect our personal information, finances and private communications. However, insecure practices in the use of passwords lead to countless security breaches and financial losses every year. The University of Jyväskylä’s SAFE Project is developing an innovation to solve the security challenges associated with passwords. […].

article thumbnail

Great timing, supercomputer upgrade lead to successful forecast of volcanic eruption

Scienmag

CHAMPAIGN, Ill. — In the fall of 2017, geology professor Patricia Gregg and her team had just set up a new volcanic forecasting modeling program on the Blue Waters and iForge supercomputers. Simultaneously, another team was monitoring activity at the Sierra Negra volcano in the Galapagos Islands, Ecuador. One of the scientists on the Ecuador […].

article thumbnail

New drug combination lengthened survival for some with lung cancer

Scienmag

A study conducted under the Lung Cancer Master Protocol (Lung-MAP) found that patients with advanced non-small cell lung cancer whose cancer had progressed on previous immunotherapy lived significantly longer when treated with a combination of ramucirumab (Cyramza®) plus pembrolizumab (Keytruda®) than when treated with one of the current standard therapies for this type of cancer. […].

Drugs 76
article thumbnail

Novel method for early disease detection using DNA droplets

Scienmag

Aqueous droplet formation by liquid-liquid phase separation (or coacervation) in macromolecules is a hot topic in life sciences research. Of these various macromolecules that form droplets, DNA is quite interesting because it is predictable and programmable, which are qualities useful in nanotechnology. Recently, the programmability of DNA was used to construct and regulate DNA droplets […].

DNA 75
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Pathways to the skies: NAU and CCC launch partnership to increase URM participation in astronomy, planetary science and other STEM fields

Scienmag

Professor David Trilling, chair of Northern Arizona University’s Department of Astronomy and Planetary Science, has been awarded a grant by the National Science Foundation to launch a new partnership with Coconino Community College (CCC). The initiative will create a pathway for recruiting 20 CCC2NAU students into paid internships working in research labs at NAU.

article thumbnail

Some blood pressure medicine may decrease the aneurysm rupture risk for people with high blood pressure

Scienmag

Embargoed until 4 a.m. CT/5 a.m. ET Friday, June 3, 2022 DALLAS, June 3, 2022 — A multi-center study of more than 3,000 people with high blood pressure and brain aneurysms found that the use of RAAS inhibitors, a class of blood pressure lowering medications, reduced the risk of an aneurysm rupture by 18%, according […].

article thumbnail

Water distribution in the fuel cell made visible in 4D

Scienmag

“In a fuel cell, hydrogen and oxygen are combined to form water. This produces electrical energy,” explains Ralf Ziesche from the imaging group at HZB. “Probably the most important component inside the fuel cell is the membrane.” It is only about 20 micrometres thick (half as wide as a human hair) and connected with various […].

article thumbnail

Repurposing cancer drug to treat neuroinflammation

Scienmag

The repurposing of FDA-approved drugs for alternative diseases is a faster way of bringing new treatments into the clinic. Researchers at Karolinska Institutet in Sweden have repurposed a cancer drug for treatment of neuroinflammatory diseases such as multiple sclerosis. A novel drug carrier was also developed to facilitate drug delivery to target myeloid cells.

Drugs 73
article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.